ICU Medical (ICUI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
ICU Medical (ICUI) last issued guidance on August 6, 2026 for fiscal year 2026. The company guided earnings per share in the range of $8.6 - $9, compared to a consensus EPS estimate of $7.83.
Compared to prior guidance, ICU Medical raised its EPS outlook from a previous range of $7.75 - $8.45.
ICU Medical has issued 15 guidance updates between August 8, 2022 and August 6, 2026. During this period, the company raised its outlook 7 times and lowered it 2 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.82 | $1.67 | $1.54 | $1.31 |
| Actual | $2.37 | $1.97 | $1.91 | $2.03 |
| Surprise | +30.2% | +18.0% | +24.0% | +55.0% |
| Revenue | ||||
| Estimate | $534.0M | $528.9M | $536.3M | $512.7M |
| Actual | $551.7M | $530.2M | $540.7M | $537.0M |
| Surprise | +3.31% | +0.25% | +0.82% | +4.74% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $2.00 | $2.00 | $1.70 | $1.75 |
| Revenue | ||||
| Consensus | $551.3M | $561.8M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $2.37 | $1.82 | 30.2 % |
| Q1 | May 7, 2026 | $1.97 | $1.67 | 18.0 % |
| Q4 | Feb 19, 2026 | $1.91 | $1.54 | 24.0 % |
| Q3 | Nov 6, 2025 | $2.03 | $1.31 | 55.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $551.70M | $534.02M | 3.31 % |
| Q1 | May 7, 2026 | $530.20M | $528.88M | 0.25 % |
| Q4 | Feb 19, 2026 | $540.70M | $536.31M | 0.82 % |
| Q3 | Nov 6, 2025 | $536.99M | $512.67M | 4.74 % |